Northwestern University Feinberg School of Medicine rose to 16th place among U.S. medical schools in National Institutes of Health funding in 2016, rising two spots in the rankings reported by the Blue Ridge Institute for Medical Research.
A Northwestern Medicine study, led by a PhD student, found that overexpressing a protein called CREB improved memory impairments in aged rats.
The addition of the drug cetuximab to standard chemoradiation reduced the incidence of relapse for patients with anal cancer, but was associated with significant adverse effects, according to recent Northwestern Medicine clinical trials.
Northwestern and Stanford scientists have uncovered new details on the structure of herpesviruses that allow them to initiate a fusion event to infect host cells.
Children with congenital heart disease have a higher risk of epilepsy through adulthood, according to a recent Northwestern Medicine study.
A recent clinical trial assessed the efficacy and safety of the drug ibrutinib in patients with Waldenstrom’s macroglobulineaemia, a type of non-Hodgkin lymphoma, who were not responding to other treatments.
Kelsey Bowman extended her medical school program from four years to five years to develop a test to map regions of the brain associated with memory.
Northwestern Medicine scientists have demonstrated an enhanced approach to targeting a type of inflammatory cell involved in atherosclerosis.
Patients with hepatitis C virus infection who received an antiviral drug around the time they underwent liver transplantation saw a high rate of sustained virologic response, according to a Northwestern Medicine clinical trial.
A drug called ustekinumab significantly improved symptoms for patients with moderate to severe Crohn’s disease, according to Northwestern Medicine clinical trials published in the New England Journal of Medicine.